மொழிபெயர்ப்பு ஆராய்ச்சி மையம் இல் ஓன்கோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses. A research team from the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE), in Switzerland, in collaboration with MaxiVAX, a spinoff of both institutions, developed an innovative technology called “cell encapsulation”. Originally designed to stimulate immunity to fight cancer, the COVID-19 pandemic motivated the scientists to broaden the scope of their technology to test its effectiveness against viruses. The first results of a pre-clinical study are very encouraging and can be discovered in the journal Vaccines. The immune system is able to identify cancer cells and fight them, just as it does against a viral or bacterial pathogen. Researchers therefore rely on this to develop vaccines against cancer. “To develop an effective vaccine, two elements are needed: a target recognized by the immune system, such as cells, proteins, DNA or

Nicolas machFaculty of medicine departmentTranslational research centre in oncoUniversity of genevaUniversity hospitals of genevaDivision of oncologyUniversity hospitalsMedicine departmentTranslational research centreஆசிரிய ஆஃப் மருந்து துறைமொழிபெயர்ப்பு ஆராய்ச்சி மையம் இல் ஓன்கோபல்கலைக்கழகம் ஆஃப் ஜிநீவபல்கலைக்கழகம் மருத்துவமனைகள் ஆஃப் ஜிநீவபிரிவு ஆஃப் புற்றுநோயியல்பல்கலைக்கழகம் மருத்துவமனைகள்மருந்து துறை